SAN CARLOS, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that senior leadership plans to present at the following virtual healthcare conferences:

See the rest here:
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *